ARCHIVES

NIH Panel Calls for Further Research On End-of-Life Issues.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Final stats On FY92 Budget; Success Rate Was 35 Percent

December 4, 1992

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis

July 22, 1977

FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24

July 3, 1981

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990